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Cardiac Magnetic Resonance Evaluation of Cardiac 
Masses in Patients with Suspicion of Cardiac Masses on 
Echo or Computed Tomography
Fateh Ali Tipoo Sultan1, Syed Waqar Ahmed1
1Department of Medicine (Cardiology), Aga Khan University Hospital, Karachi, Sindh, Pakistan.
INTRODUCTION
Primary cardiac tumors are rare, with an estimated prevalence of 0.001–0.03% at autopsy.[1,2] 
Approximately 75% of all primary cardiac tumors are benign, with myxomas being the most 
frequent lesions.
ABSTRACT
Objectives: In recent years, cardiac magnetic resonance (CMR) imaging has emerged as an important tool in 
the identification and characterization of cardiac masses. No imaging data on cardiac masses are available from 
Pakistan. We aimed to review the clinical presentation, CMR findings, and outcome of patients referred for CMR 
due to suspicion of cardiac masses on echocardiogram or computed tomography (CT).
Material and Methods: We reviewed all the patients referred for CMR at Aga Khan University Hospital, Karachi, 
from January 2011 to March 2020, with the suspicion of cardiac mass on echocardiogram and/or CT. Only those 
with the confirmed diagnosis of cardiac mass on CMR were included in the study.
Results: A total of 27 patients were referred for CMR from January 2011 to March 2020, with the suspicion of 
cardiac mass on echocardiogram and/or CT. Four patients were excluded as no cardiac mass was found on CMR. 
Out of 23 cases, majority (n = 15, 65%) were female, age ranging from 3 months to 70 years, with a mean age 
of 40 ± 22 years. Shortness of breath was the main presenting symptom (n = 19, 83%). Echocardiogram was 
the initial imaging modality done in all the patients while CT was also performed in 6 patients (26%). Out of 
23 patients, 4 (17%) were diagnosed to have thrombus on CMR. In two cases, it was in the left ventricle with 
evidence of myocardial infarction on late gadolinium images. Myxoma was the most common tumor diagnosed 
on CMR in 6 patients (26%) followed by rhabdomyoma (n = 3, 13%) and fibroma (n = 2, 8.7%). ere were three 
malignant primary tumors of the heart based on CMR appearances and one with tumor thrombus extension 
of hepatocellular carcinoma in the right atrium from inferior vena cava. Two patients were diagnosed to have 
non-neoplastic lesions – one with large intracardiac hydatid cyst and one with possible large fungal vegetation. 
Among 23 patients, 9 patients (39%) underwent surgery, 5 with myxoma, 2 with rhabdomyoma, 1 with fibroma, 
and 1 with fibroelastoma. Findings on surgery and histopathology matched the CMR diagnosis in all the patients 
except the one with the CMR diagnosis of myxoma in which histopathology was consistent with thrombus.
Conclusion: CMR can play an important role in confirming the presence or absence of a mass in the heart. It 
can also provide differentiation of non-neoplastic and neoplastic lesions and among different types of neoplastic 
lesions with reasonable accuracy. However, the limitations of CMR must be recognized.
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Cardiac tumors, although rare, are important and 
technically difficult to diagnose using current imaging 
modalities. Transthoracic echocardiography is the most 
readily available non-invasive imaging technique and thus 
remains the first-line diagnostic test when a cardiac tumor 
is suspected.[3] However, tissue characterization by means 
of echocardiography is generally limited. Cardiac computed 
tomography (CT) is a commonly used second-line diagnostic 
modality to assess cardiac masses.[4]
Cardiovascular magnetic resonance (CMR) imaging provides 
comprehensive information and has emerged as an important 
test in the identification and characterization of cardiac 
masses.[5-7] CMR is non-invasive, with no risk of ionizing 
radiation and wide field of view. It also provides information 
about cardiac morphology and function. Compared with 
CT, CMR imaging offers higher temporal resolution and 
additional tissue characterization.
Cardiac masses may be non-neoplastic, for example, thrombi 
or large vegetation. When there is clinical suspicion of a 
cardiac mass, proper diagnostic evaluation is necessary for 
appropriate treatment. CMR is important in the evaluation of 
such lesions due to better tissue characterization. 
No imaging data on cardiac masses are available from 
Pakistan. We aimed to do the study to review the clinical 
presentation, CMR findings, and outcome of patients 
referred for CMR due to suspicion of cardiac masses on 
echocardiogram or CT. is is the first study of its kind from 
Pakistan. With the help of this study, we will get an idea about 
the clinical presentation and type of cardiac tumors present 
in this region and the investigative strategy which should be 
adapted for the workup of cardiac masses.
MATERIAL AND METHODS
Study design
is is a retrospective observational study.
Study population and data collection
e study was started after getting approval from Ethical 
Review Committee of Aga Khan University Hospital 
(AKUH), Karachi. CMR imaging was started at AKUH, 
Karachi, in 2011. We reviewed all the patients referred for 
CMR at AKUH, Karachi, from January 2011 to March 2020, 
with the suspicion of cardiac mass on echocardiogram and/or 
CT. Only those with the confirmed diagnosis of cardiac mass 
on CMR were included in the study. Data were collected by 
reviewing electronic records and patients’ charts. Variables of 
interest were recorded using a predesigned data entry form. 
Follow-up data for surgery, histopathology, and death were 
recorded by reviewing the hospital records and telephone 
calls where necessary.
CMR data acquisition
CMR was performed using a 1.5T Siemens Avanto scanner. In 
each patient, a standard cardiac mass protocol was used which 
included assessment of cardiac masses by morphological, 
functional, and tissue characterization sequences. Images 
were acquired in conventional planes and also in other planes 
which best demonstrated the cardiac mass in each case.
A breath-hold steady-state free precession ECG-triggered 
sequence was used for anatomical and functional assessment. 
e other sequences which were obtained included turbo 
spin echo T1- and T2-weighted images with and without 
fat saturation, first-pass perfusion (FPP) images with 
gadolinium, and late gadolinium enhancement (LGE) 
images. e inversion time was optimized to null signal from 
the normal myocardium.
CMR data analysis
All the images were analyzed and read by an experienced 
reader in cardiovascular imaging, who was also present 
at the time of image acquisition in each case. e tumor 
characteristics which were assessed on CMR included tumor 
size, location, attachment and mobility, signal characteristics 
on different sequences, and the presence of pericardial 
effusion. Signal intensity on various sequences was assessed 
as hypointense, isointense, and hyperintense in relation to the 
normal myocardium. Perfusion of the tumor was assessed on 
FPP images and late enhancement on LGE images.
In addition, the left and right ventricular volumes and 
ejection fraction were calculated by manually drawing the 
endocardial and epicardial borders in end diastole and end 
systole, on the series of short-axis cine slices, using a third-
party software – Medis QMass.
Statistical analysis
All the demographic details, presenting symptoms, CMR 
findings, follow-up details about surgery, histopathology, 
and outcome, were recorded. After creating a database, the 
data were encoded. All statistical analyses were performed 
using the Statistical Package for the Social Sciences 
version 24. Continuous variables were expressed as mean 
value ± standard deviation and categorical variables were 
expressed as frequencies and percentage.
RESULTS
Clinical presentation
A total of 27 patients were referred for CMR from January 
2011 to March 2020, with the suspicion of cardiac mass on 
echocardiogram and/or CT. Four patients were excluded as 
no cardiac mass was found on CMR.
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Baseline characteristics of these 23 patients are summarized 
in Table  1. Out of 23 cases, majority (n = 15, 65%) were 
female, age ranging from 3 months to 70 years with a mean 
age of 40 ± 22 years. Shortness of breath was the main 
presenting symptom (n = 19, 83%). Echocardiogram was the 
initial imaging modality done in all the patients while CT 
was also done in 6 patients (26%).
CMR diagnosis
Table 2 shows the differentiation and frequency of different 
types of cardiac masses on CMR. Out of 23 patients, 4 
(17%) were diagnosed to have thrombus on CMR. In two 
cases, it was in the left ventricle with evidence of myocardial 
infarction on late gadolinium images. Rest of the two patients 
had a history of breast carcinoma – one showed thrombus in 
the right ventricle and the other in the right atrium (RA).
Myxoma was the most common tumor diagnosed on 
CMR in 6 patients (26%), followed by rhabdomyoma 
(n = 3, 13%), fibroma (n = 2, 8.7%), hemangioma (n =1, 
4.3%), and fibroelastoma (n = 1, 4.3%). ere were three 
malignant primary tumors of the heart based on CMR 
characteristics and one with tumor thrombus (TT) extension 
of hepatocellular carcinoma (HCC) in the RA from inferior 
vena cava (IVC).
One patient was diagnosed to have large intracardiac 
hydatid cyst embedded in the interventricular septum and 
occupying major part of the right ventricle. Another rare 
case was of possible fungal vegetation in the right ventricle 
attached near the tricuspid valve. It was a probable diagnosis 
based on a combination of clinical features of fever, 
hemoptysis, CT findings of large mycetoma in the lung 
with damaged lungs due to prior tuberculosis, and large 
vegetation/mass in the right ventricle on echocardiogram 
and CMR.
CMR characteristics
Table  3 shows the CMR characteristics of the benign and 
malignant tumors found in this study. e most common 
location was intracavitary with the RA being the most 
common chamber involved.
Follow-up and outcome
Among 23 patients, 9 patients (39%) underwent surgery, 5 
with myxoma, 2 with rhabdomyoma, 1 with fibroma, and 1 
with fibroelastoma. Findings on surgery and histopathology 
matched the CMR diagnosis in all the patients except the one 
with the CMR diagnosis of myxoma in which histopathology 
was consistent with thrombus.
ree patients with CMR diagnosis of primary malignant 
cardiac tumor died before any biopsy or surgical procedure. 
Unfortunately, we could not confirm the diagnosis by 
histopathology as all of them were very sick and died before 
we could have done any procedure. One had CMR features of 
cardiac lymphoma and the other two were non-differentiated 
malignant tumors in the RA with infiltrative features and the 
presence of pericardial effusion.
One fibroma patient died during the surgery and one myxoma 
patient died few months after the surgery. is patient had 
histologically proven right atrial myxoma with Budd-Chiari 
syndrome. e patient died due to complications of Budd-
Chiari syndrome.
Patients with cardiac thrombi were managed with 
anticoagulation and showed regression in the size of thrombi 
on subsequent echocardiograms.
Table 1: Baseline characteristics.
Characteristics Number of patients 
(n=23)
Percentage 
Age (Mean±SD) 40±22 -
Male 8 34.8
Hypertension 8 34.8
Diabetes mellitus 2 8.7
Coronary artery disease 2 8.7
Chest pain 2 8.7




Pulmonary embolism 5 21.7
Stroke 3 13
History of tumor 2 8.7
ST-T changes on ECG 3 13




rombus 4 (+1) 17.4





Probable lymphoma 1 4.3
Undifferentiated primary malignant 
tumor
2 8.7
Tumor thrombus extension from 
hepatoma
1 4.3
Intracardiac hydatid cyst 1 4.3
Possible large fungal vegetation 1 4.3
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DISCUSSION
Although small, this is the first study on CMR assessment of 
cardiac masses from this region. is study shows that CMR 
is excellent in excluding cardiac masses and has high accuracy 
in differentiating between different types of cardiac masses. 
However, similar to other imaging modalities, CMR also has 
certain limitations and some cases could be misdiagnosed. 
When there is uncertainty about the correct diagnosis, 
histopathological assessment should be considered.
Cardiac thrombi
rombi are the lesions which are usually confused with 
cardiac tumors. In our study, thrombus was found in 17% 
(n = 4) of the patients with confirmed cardiac mass on CMR. 
e left ventricle was the site in two patients, one patient had 
thrombus in the RA and one had it in the right ventricle. 
e left ventricular thrombi are seen in patients with poor 
myocardial contractility, usually attached to the infarcted or 
scarred myocardium.[8] In our study, both the patients with 
the left ventricular thrombus showed evidence of myocardial 
infarction on late gadolinium images [Figure  1a-c], which 
was not appreciated on echocardiogram. Rest of the two 
patients had a history of breast carcinoma with apparently 
hypercoagulable state.
e left atrium is another common site for cardiac thrombi, but 
in our study, no patient was found with the left atrial thrombus. 
e left atrial thrombi, especially in the left atrial appendage, 











Age, mean±SD 48±17 5±2 mon. 26±17 35 47±23
Male, n (%) 1 (20) 1 (33.3) 1 (50) 0 2 (50)
Tumor location, n (%)
Left atrium 2 (40) 0 (0) 0 (0) 0 (0) 0 (0)
Right atrium 3 (60) 1 (33.3) 0 (0) 0 (0) 3 (75)
Left ventricle 0 (0) 1 (33.3) 1 (50) 1 (100) 0 (0)
Right ventricle 0 (0) 0 (0) 0 (0) 0 (0) 0 (0)
Interatrial septum 0 (0) 0 (0) 0 (0) 0 (0) 1 (25)
Interventricular septum 0 (0) 0 (0) 1 (50) 0 (0) 0 (0)
Pericardium 0 (0) 1 (33.3) 0 (0) 0 (0) 0 (0)
Pericardial effusion
Yes 0 (0) 0 (0) 0 (0) 0 (0) 3 (75)
No 5 (100) 3 (100) 2 (100) 1 (100) 0 (0)
T1-weighted images
Iso 3 (60) 3 (100) 1 (50) 1 (100) 0 (0)
Hypo 0 (0) 0 (0) 0 (0) 0 (0) 0 (0)
Hypo to iso 1 (20) 0 (0) 0 (0) 0 (0) 0 (0)
Hyper 0 (0) 0 (0) 0 (0) 0 (0) 1 (25)
Iso to hyper 0 (0) 0 (0) 1 (50) 0 (0) 1 (25)
Indeterminate 1 (20) 0 (0) 0 (0) 0 (0) 2 (50)
T2-weighted images
Iso 0 (0) 0 (0) 1 (50) 1 (100) 0 (0)
Hypo 0 (0) 0 (0) 1 (50) 0 (0) 0 (0)
Hypo to iso 0 (0) 0 (0) 0 (0) 0 (0) 0 (0)
Hyper 2 (40) 2 (66.7) 0 (0) 0 (0) 1 (25)
Iso to hyper 2 (40) 1 (33.3) 0 (0) 0 (0) 1 (25)
Indeterminate 1 (20) 0 (0) 0 (0) 0 (0) 2 (50)
First-pass perfusion
Yes 4 (80) 2 (66.7) 2 (100) 1 (100) 3 (75)
No 0 (0) 1 (33.3) 0 (0) 0 (0) 0 (0)
Indeterminate 1 (20) 0 (0) 0 (0) 0 (0) 1 (25)
LGE
No 3 (60) 2 (66.7) 0 (0) 0 (0) 1 (25)
Yes – patchy, heterogeneous 2 (40) 1 (33.3) 0 (0) 1 (100) 2 (50)
Yes – homogeneous, intense 0 (0) 0 (0) 2 (100) 0 (0) 0 (0)
Indeterminate 0 (0) 0 (0) 0 (0) 0 (0) 1 (25)
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are seen in patients with atrial fibrillation and mitral stenosis. 
ese are easily picked up on transesophageal echocardiogram 
and the patients are usually not referred for CMR.
On CMR, signal intensity of thrombi varies on different 
sequences according to their age. ey are usually described 
as hypointense masses without enhancement on postcontrast 
images.[9] Subacute thrombi are iso- to hyper-intense on T1-
weighted images and hypointense on T2-weighted images. 
Organized chronic thrombi are hypointense on both T1- 
and T2-weighted images due to the presence of hemosiderin 
deposits.[10,11] As neoplastic lesions usually have a vascularized 
tissue component and thrombi are avascular, perfusion images 
and LGE images are important in differentiating tumors from 
thrombi. However, in chronic thrombi, some peripheral 
enhancement have been reported on LGE images.[10,12]
Benign tumors
CMR features which allow us to differentiate between benign 
and malignant cardiac tumors include borders, location, and 
pericardial effusion. Benign tumors are usually well defined 
with no irregularities or infiltration.[13]
Myxoma
Myxoma is the most common benign primary cardiac tumor, 
found predominantly in women with the majority occurring 
in the left atrium.[14] is was also true for our study, where 
myxoma was the most common primary cardiac tumor with 
female preponderance, but the distribution of location was 
different. ree (60%) were in the RA while 2 (40%) in the 
left atrium [Figure 2a-c].
Myxomas are pedunculated masses, usually attached to the 
interatrial septum. ere is heterogeneous signal intensity 
on various CMR sequences, depending on the content of 
the lesion. ey are usually isointense to hypointense on T1-
weighted images and hyperintense on T2-weighted images 
probably due to high water content in the myxomatous tissue. 
ey usually contain myxoid material as well as necrotic 
or cystic and calcified material.[15] In our study, myxomas 
showed similar CMR features as prior reports.[7] One case of 
thrombus, which was misdiagnosed as myxoma on CMR was 
a female with history of antiphospholipid antibody syndrome 
and a mass in the RA near the IVC. e histopathology 
showed that it was a thrombus.
Rhabdomyoma
Rhabdomyoma is the most common primary cardiac 
tumor in infants and children.[16] Cardiac rhabdomyomas 
are predominantly localized within the ventricles but can 
be observed in the atria and may lead to obstruction of 
inflow or outflow tracts. ey are usually asymptomatic but 
may also cause arrhythmias. ere is a strong correlation 
between cardiac rhabdomyomas and tuberous sclerosis. In 
Figure  1: A 35-year-old female presented with embolic stroke, 
diagnosed to have left ventricular apical thrombus with evidence of 
myocardial infarction. (a) Cardiac magnetic resonance steady-state 
free precession still frame in diastole showing filling defect at the left 
ventricular apex (arrow). (b) Cardiac magnetic resonance steady-
state free precession still frame in systole showing non-contracting 
left ventricular apex with filling defect (arrow). (c) Cardiac magnetic 
resonance delayed enhanced image with gadolinium, showing 





Figure  2: A 70-year-old female presented dyspnea and syncope, 
diagnosed to have left atrial myxoma. (a) Cardiac magnetic 
resonance steady-state free precession still frame showing large 
myxoma in the left atrium (arrow). (b) Cardiac magnetic resonance 
turbo spin echo T1-weighted image, myxoma showing hypointense 
to isointense signal (arrow). (c) Cardiac magnetic resonance turbo 
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our study, all the three cases of rhabdomyomas were children 
under 1 year of age [Figure 3a and b], and two of them were 
diagnosed to have tuberous sclerosis. One of the patients had 
multiple lesions involving both the left and right ventricles.
On CMR, rhabdomyomas are isointense relative to the 
myocardium on T1-weighted images and hyperintense on 
T2-weighted images. No significant enhancement is usually 
seen on LGE images. Surgical resection is not usually 
considered unless they cause symptoms of obstruction, 
heart failure, or arrhythmias. However, in our study, two of 
the cases underwent surgery due to unusual location, one 
occupying the pericardium and the other in the RA, with 
histopathology confirming the diagnosis.
Cardiac fibroma
Cardiac fibroma is considered the second most common 
pediatric primary cardiac tumor, usually seen as a single 
lesion in an intramyocardial location.[17] In our study, 
both the cases present as a well-defined mass, one in the 
interventricular septum [Figure  4a-d] and the other in the 
free wall of the left ventricle. One case was a 14-year-old boy 
while the other was a female of 38 years.
Clinical presentation of patients with cardiac fibroma 
depends on the location and size of the tumor. ey can 
present with symptoms of heart failure and arrhythmias. 
In our study, both presented with progressively worsening 
shortness of breath. In a systemic review,[18] the left 
ventricle was found to be the most common site of cardiac 
fibroma (57.3%), followed by the right ventricle (27.5%), 
interventricular septum (17%), RA (5.3%), and left atrium 
(1.8%). In our study, one was in the interventricular septum 
and the other in the free wall of the left ventricle.
Fibromas are isointense to hyperintense compared to 
myocardium on T1-weighted images and hypointense on T2-
weighted images.[19] Intense and homogeneous enhancement 
on late gadolinium images is a characteristic finding of 
fibroma on CMR. is is due to the accumulation and 
retention of the contrast material in the wide extracellular 
space of the fibrous tissue of the tumor.[20]
Surgical excision of fibromas is usually difficult as these 
are embedded in the myocardium. One of our patients 
underwent surgery and died on the table.
Hemangioma
Cardiac hemangiomas are usually located in the ventricles 
and account for approximately 5% of cardiac tumors. 
ey may occur in either endocardium, myocardium, 
or epicardium. On CMR SSFP cine images, cardiac 
hemangioma appears as a non-mobile, non-contractile mass. 
ey are isointense on T1-weighted images and hyperintense 
on T2-weighted images. On LGE images, they show intense 
enhancement with usually heterogeneous appearance due to 
fibrous septum and calcification.[19] One patient had cardiac 
hemangioma in our study, located in the lateral wall of the 
left ventricle [Figure 5a-c].
Fibroelastoma
Fibroelastoma or papillary fibroelastoma (PFE) is the most 
common primary tumor of cardiac valves and usually 
Figure  3: A 3-month-old baby girl diagnosed to have right atrial 
rhabdomyoma. (a) Cardiac magnetic resonance turbo spin echo 
T1-weighted image, right atrial rhabdomyoma showing isointense 
signal (arrow). (b) Cardiac magnetic resonance turbo spin echo T2-
weighted image, right atrial rhabdomyoma showing hyperintense 
signal (arrow).
ba
Figure 4: A 38-year-old female presented with gradually worsening 
dyspnea. Diagnosed to have large fibroma in the interventricular 
septum. (a) Cardiac magnetic resonance steady-state free 
precession still frame, showing large fibroma in the interventricular 
septum (arrow). (b) Cardiac magnetic resonance turbo spin echo 
T1-weighted image, fibroma showing isointense signal (arrow). 
(c) Cardiac magnetic resonance turbo spin echo T2-weighted 
image, fibroma showing hypointense signal (arrow). (d) Cardiac 
magnetic resonance delayed enhanced image with gadolinium, 
fibroma showing intense homogeneous enhancement (arrow).
a b
dc
Journal of Clinical Imaging Science • 2020 • 10(57) | 7
Sultan and Ahmed: Cardiac magnetic resonance evaluation of cardiac masses
located on the left side.[21] Its origin from non-valvular 
endocardium is extremely rare. Fibroelastomas are small, 
mobile, pedunculated lesions. On CMR, fibroelastomas 
are isointense on T1-weighted images and hyperintense 
on T2-weighted images. In our study, fibroelastoma was 
found in only one patient on CMR and was confirmed on 
surgery and histopathology. is was a 49-year-old man with 
fibroelastoma in the RA, attached to the IVC at its junction to 
the RA [Figure 6a and b]. Origin of fibroelastoma from the 
RA is extremely rare with an estimated incidence of 1.8–2.3% 
and non-valvular right atrial PFE is even rarer.[22] e right 
atrial PFEs generally remain asymptomatic until they grow 
larger in size. In our case, it was found incidentally on workup 
of liver abscess. ey can be fatal due to their propensity to 
embolize. All symptomatic patients and patients with the 
right atrial PFE of more than 10 mm should undergo surgical 
resection.
Malignant tumors
In contrast to benign tumors, malignant cardiac tumors 
are more likely to be ill-defined, with invasive borders and 
may already be invading the pericardium at the time of 
diagnosis.[23] Malignant primary cardiac tumors include 
sarcomas, lymphomas, and mesothelial tumors. Sarcomas 
are neoplasia of mesenchymal origin and may involve one or 
more chambers as large masses occupying the entire affected 
chamber or multiple chambers, with ill-defined margins and 
invasive features. Associated pericardial effusion is often 
present. On CMR, there may be heterogeneous enhancement 
due to the presence of necrosis and hemorrhage.[15] Sarcomas 
show aggressive characteristics and usually have a fatal 
outcome.
In our study, there were three malignant primary cardiac 
tumors based on CMR characteristics. All three patients were 
very sick and died before any surgical procedure or biopsy. 
In the two cases, the RA was the site of location of the tumor 
with infiltrating features and presence of pericardial effusion 
favoring the diagnosis of malignant tumor. ese were 
probably cardiac sarcomas, but we cannot be certain in the 
absence of histopathology.
Cardiac lymphomas usually present as large, bulky masses 
with vascular encasement without obliterating the lumen.[5,24] 
In our study, one patient was probably having the cardiac 
lymphoma based on CMR features. is was a 68-year-old 
man with a history of weight loss, night sweats, and shortness 
of breath. e tumor was involving the whole interatrial 
septum and the roof of both atria, further extending outside 
the heart to encase the great vessels [Figure 7a and b]. Mild-
to-moderate pericardial effusion was also present.
Secondary metastasis to the heart frequently manifests 
as pericardial effusion. e tumors that can commonly 
metastasize to the heart are melanoma, lung, breast, kidney, 
and esophageal carcinomas.[25-27] Cardiac involvement may 
be due to direct spread, through lymphatics, hematogenic 
dissemination, or transvenous extension. On CMR, 
there is no specific appearance of metastatic lesions and 
signal characteristics are variable. However, postcontrast 
enhancement occurs in almost all types of metastatic 
lesions.[18]
In our study, no case of secondary metastatic lesion was found 
except one with TT extension of HCC to the RA through the 
Figure 5: A 35-year-old female presented with dyspnea diagnosed 
to have cardiac hemangioma in the lateral wall of the left ventricle. 
(a) Cardiac magnetic resonance steady-state free precession still 
frame, showing hemangioma in the lateral wall of the left ventricle 
(arrow). (b) Cardiac magnetic resonance first-pass perfusion image 
with gadolinium showing good perfusion in the hemangioma 
(arrow). (c) Cardiac magnetic resonance delayed enhanced image 




Figure  6: A 49-year-old male incidentally found to have 
fibroelastoma in the right atrium, during the workup of liver 
abscess. (a) Cardiac magnetic resonance steady-state free precession 
still frame, showing fibroelastoma attached to the inferior vena 
cava at its junction to the right atrium (arrow). (b) Cardiac 
magnetic resonance steady-state free precession still frame, showing 
fibroelastoma attached to the inferior vena cava at its junction to the 
right atrium (arrow).
ba
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IVC. No case with secondary metastatic lesion may be due to 
the referral bias as patients with secondary metastatic lesions 
to the heart are usually diagnosed on echocardiogram or CT 
and are not referred for CMR.
HCC is an aggressive tumor with a tendency to grow into the 
blood vessels. IVC to the RA TT is an infrequent but well-
recognized complication of HCC with an incidence of 3–4% 
in patients of HCC who undergo diagnostic imaging.[28] It is 
associated with an increased risk of pulmonary embolism, 
systemic metastases, and sudden cardiac arrest. e patient 
with TT extension of HCC from IVC to RA in our study was 
a known case of chronic liver disease and presented with 
worsening shortness of breath. Echocardiogram revealed a 
large irregular mass in the RA. Further, workup with CMR 
and CT confirmed the diagnosis of HCC, with TT extension 
to RA and evidence of pulmonary embolism [Figure  8a-c]. 
Due to lack of specific clinical signs, this condition is 
probably underdiagnosed. However, with the improved 
imaging studies, the incidence is increasing now. Patients 
with advanced stage of the tumor or decompensated liver 
disease are not suitable candidates for surgical treatment.
CONCLUSION
CMR can play an important role in confirming the presence or 
absence of a mass in the heart. It can also provide differentiation 
of non-neoplastic and neoplastic lesions and among different 
types of neoplastic lesions with reasonable accuracy. However, 
the limitations of CMR must be recognized.
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